Iambic Therapeutics
Tracked across 1 events · 6 articles · First seen Sep 21, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Iambic Therapeutics, a San Diego-based drug developer backed by Nvidia and the Qatar Investment Authority, filed for a US initial public offering on Monday, September 21, 2026, aiming to list on the Nasdaq under the…
Impact: The central entity of the event, filing for a US IPO on Nasdaq under symbol IAM and unveiling an AI drug discovery collaboration with AbbVie. A successful listing would give it fresh capital and public-market valuation.
Sep 21, 2026 · 6 articles
95
Iambic Therapeutics filed for IPOIambic Therapeutics Files...
70
Iambic Therapeutics unveiled collaboration AbbVieIambic Therapeutics Files...
ERGEN INTELLIGENCE
Track Iambic Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard